These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytes. Nikolova M; Guenova M; Taskov H; Marie-Cardine A; Boumsell L; Bensussan A Cell Immunol; 2005; 236(1-2):92-100. PubMed ID: 16197933 [TBL] [Abstract][Full Text] [Related]
7. B-cell malignancies and differentiation antigens defined with monoclonal antibodies. Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375 [TBL] [Abstract][Full Text] [Related]
8. Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies. Tazzari PL; Gobbi M; Dinota A; Bontadini A; Grassi G; Cerato C; Cavo M; Pileri S; Caligaris-Cappio F; Tura S Clin Exp Immunol; 1987 Oct; 70(1):192-200. PubMed ID: 3319299 [TBL] [Abstract][Full Text] [Related]
9. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431 [TBL] [Abstract][Full Text] [Related]
10. Distribution of a new B-cell-associated surface antigen (BL7) detected by a monoclonal antibody in human leukemic disorders. Al-Katib A; Wang CY; Koziner B Cancer Res; 1985 Jul; 45(7):3058-63. PubMed ID: 3924396 [TBL] [Abstract][Full Text] [Related]
11. New monoclonal antibodies SN3, SN3a, and SN3b directed to sialic acid of glycoprotein on human non-T leukemia cells. Fukukawa T; Matsuzaki H; Haruta Y; Hara H; Seon BK Exp Hematol; 1986 Oct; 14(9):850-5. PubMed ID: 3489635 [TBL] [Abstract][Full Text] [Related]
12. Identification of an early activation antigen (Bac-1) on human B cells. Suzuki T; Sanders SK; Butler JL; Gartland GL; Komiyama K; Cooper MD J Immunol; 1986 Aug; 137(4):1208-13. PubMed ID: 3090143 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. Sidorenko SP; Clark EA J Immunol; 1993 Nov; 151(9):4614-24. PubMed ID: 8409422 [TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes. Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242 [TBL] [Abstract][Full Text] [Related]
15. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors. Epstein AL; Marder RJ; Winter JN; Fox RI J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628 [TBL] [Abstract][Full Text] [Related]
16. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules. Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes. Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400 [TBL] [Abstract][Full Text] [Related]